CC
STIM icon

Centiva Capital’s Neuronetics STIM Stock Holding History

Centiva Capital’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$372K Buy
285,913
+116,594
+69% +$170K ﹤0.01% 1061
2026
Q1 		$246K Buy
+169,319
New +$268K ﹤0.01% 1167
2025
Q4 		– Sell
-117,322
Closed -$320K – 1576
2025
Q3 		$320K Buy
117,322
+61,501
+110% +$218K ﹤0.01% 742
2025
Q2 		$195K Sell
55,821
-33,683
-38% -$133K ﹤0.01% 1346
2025
Q1 		$329K Buy
+89,504
New +$327K 0.01% 1032

Other funds holding STIM

MAM
Madryn Asset Management New York $36.9M AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
FCM
FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MCM
Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Centiva Capital's STIM Position: Q2 2026 in Review

Centiva Capital increased its Neuronetics (STIM) stake by 69% in Q2 2026, buying an estimated $170K and bringing the position to 285,913 shares worth $372K. The position accounts for ﹤0.01% of the portfolio, ranked #1061.

Centiva Capital first reported a position in STIM in Q1 2025 and has held it in 5 quarters since. 86 funds tracked by Wall St. Rank hold STIM as of Q2 2026.

  • Centiva Capital held 285,913 shares of Neuronetics worth $372K as of Q2 2026.
  • Centiva Capital bought 116,594 Neuronetics shares in Q2 2026, an estimated $170K.
  • Neuronetics made up ﹤0.01% of Centiva Capital's portfolio in Q2 2026, its #1061 holding.
  • Centiva Capital first reported a position in Neuronetics in Q1 2025 and has held it in 5 quarters since.
  • 86 funds tracked by Wall St. Rank held Neuronetics as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.